PC12 cells were maintained on collagen-coated plates in DME with 6% FCS and 6% horse serum and seed at 6 × 105 cells per 6-cm dish before transfection using FuGene reagent (Roche) according to the manufacturer's instructions. Each transfection mix (4 μg total plasmid DNA) included SRF reporter plasmid 3D.ALuc (firefly luciferase; 0.1 μg), reference standard pRLTK (thymidine kinase promoter controlling renilla luciferase; 0.4 μg), EF-eGFP (0.2 μg) to monitor transfection efficiency, and EFplink expression vector or derivatives encoding activator proteins or FLAG–cofilin (3.3 μg). For phosphorylation studies, cofilin expression plasmids were used at 0.2 μg per transfection. From control immunoblotting experiments with transfection efficiency estimated using GFP, we estimate that FLAG–cofilin was overexpressed by between two- and fivefold (unpublished data). Transfected cells were maintained in 0.5% serum for 18 h before stimulation with 15% serum; lysates were prepared 8 h later. For reporter experiments, activities were normalized to the activity of a parallel control transfection in which reporter activation was achieved using the constitutively active SRF derivative SRFVP16 (50 ng; Dalton and Treisman, 1992 (link)), taken as 100. Each reporter figure shows mean ± SEM for at least three independent transfection experiments. RNA analysis and transfection of mouse NIH3T3 cells were performed as previously described (Sotiropoulos et al., 1999 (link)); total RNA (10 μg) was analyzed using mouse GAPDH and vinculin probes with RNase T1 digestion (8 U per hybridization). Drug treatments were as follows: cytochalasin D (2 μM; Calbiochem); jasplakinolide (0.5 μM; Molecular Probes); pretreatments for 45 min with Y27632 (10 μM; gift from Yoshitomi Corp, Osaka, Japan) or latrunculin B (0.5 μM; Calbiochem).
>
Chemicals & Drugs
>
Amino Acid
>
Vinculin
Vinculin
Vinculin is a cytoskeleton protein that plays a critical role in cell-cell and cell-matrix adhesion.
It is involvd in the formation and regulation of focal adhesions, which are important for cell migration, signaling, and mechanical force transmission.
Vinculin interacts with a variety of other proteins, including actin, talin, and α-actinin, to mediate these adhesive processes.
Dysregulation of vinculin has been implicated in a number of diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions.
Understanding the functions and regulation of vinculin is an active area of research, with potential therapeutic applications.
It is involvd in the formation and regulation of focal adhesions, which are important for cell migration, signaling, and mechanical force transmission.
Vinculin interacts with a variety of other proteins, including actin, talin, and α-actinin, to mediate these adhesive processes.
Dysregulation of vinculin has been implicated in a number of diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions.
Understanding the functions and regulation of vinculin is an active area of research, with potential therapeutic applications.
Most cited protocols related to «Vinculin»
Actin Depolymerizing Factors
Cells
Cloning Vectors
Collagen
Crossbreeding
Cytochalasin D
derivatives
Digestion
Equus caballus
FuGene
GAPDH protein, human
Hyperostosis, Diffuse Idiopathic Skeletal
jasplakinolide
latrunculin B
Luciferases, Firefly
Luciferases, Renilla
Molecular Probes
Mus
NIH 3T3 Cells
PC12 Cells
Pharmaceutical Preparations
Phosphorylation
Plasmids
Proteins
Ribonuclease T1
Serum
Thymidine Kinase
Transfection
Vinculin
Y 27632
2-Mercaptoethanol
ABI2 protein, human
Actins
Antibodies
Buffers
Caspase 3
Clone Cells
Destrin
Filamin A
Glutathione
NCKAP1 protein, human
Nonmuscle Myosin Type IIA
Proteins
Reducing Agents
SDS-PAGE
SLC3A2 protein, human
Talin
Tubulin
Vinculin
Human HeLa, HCC1395, 293T and U2OS cells were grown in Dulbecco’s modified Eagle’s medium (DMEM), while SH-SY5Y were grown in DMEM/F12 (1:1). Media was supplemented with 10% fetal calf serum. For BRCA2 gene knockout, the commercially available BRCA2 CRISPR/Cas9 KO plasmid was used (Santa Cruz Biotechnology sc-400700). Transfected cells were FACS-sorted into 96-well plates using a BD FACSAria II instrument. Resulting colonies were screened by western blot. Cell extracts, chromatin fractionation and western blot experiments were performed as previously described (29–31 (link)). Antibodies used for Western blot were: BRCA2 (Bethyl A303-434A), GAPDH (Santa Cruz Biotechnology sc-47724), RAD51 (Santa Cruz Biotechnology sc-8349), Vinculin (Santa Cruz Biotechnology sc-73614), RAD52 (Santa Cruz Biotechnology sc-365341). For gene knockdown, cells were transfected with Stealth siRNA (Life Tech) using Lipofectamine RNAiMAX reagent. For co-depletion experiments, control (non-targeting) siRNA was added to the targeting siRNA in the single knockdown samples to equalize total siRNA levels. The siRNA targeting sequences used were: E2F7 #1: GGACGATGCATTTACAGATTCTCTA; E2F7 #2: GACTATGGGTAACAGGGCATCTATA; E2F7 #3: AAACAAAGGTACGACGCCTCTATGA (used for E2F7 knockdown unless otherwise mentioned); BRCA2: GAGAGGCCTGTAAAGACCTTGAATT; RAD51: CCATACTGTGGAGGCTGTTGCCTAT; RAD52: GGCCAATGAGATGTTTGGTTACAAT.
Antibodies
Cell Extracts
Cells
Chromatin
Clustered Regularly Interspaced Short Palindromic Repeats
Eagle
Fetal Bovine Serum
GAPDH protein, human
Gene, BRCA2
Gene Knockdown Techniques
Gene Knockout Techniques
HeLa Cells
Homo sapiens
Lipofectamine
Plasmids
RAD52 protein, human
Radiotherapy Dose Fractionations
RNA, Small Interfering
Vinculin
Western Blot
A-301
Antibodies
Benzonase
Biological Assay
BRD4 protein, human
Buffers
Cells
Centrifugation
GAPDH protein, human
HEK293 Cells
inhibitors
MAP2K1 protein, human
Mitogen-Activated Protein Kinase 3
NIH 3T3 Cells
Phosphoric Monoester Hydrolases
Protease Inhibitors
Protein Isoforms
Proteins
Radioimmunoprecipitation Assay
RNA Polymerase II
Tacrolimus Binding Protein 1A
Vinculin
The expression plasmid for GFP–CP was constructed from pEGFP-C1 (Clontech , Palo Alto, CA) and a cDNA encoding mouse CP-β2 (53 (link)). The expression plasmid for GFP–Arp3 was described (66 (link)). The expression plasmids for mutant forms of rac1 and cdc42 were as described (13 (link)). The plasmids for expression of LIM–kinase-1 and mutant LIM–kinase-1 were as described (2 (link)). Exoenzyme C3 transferase was purchased from Calbiochem-Novabiochem (La Jolla, CA). Activated RhoA was expressed in bacteria and purified as described (48 (link)). The expression plasmid for mouse phosphatidylinositol 5-kinase (PI 5-kinase) (GenBank/EMBL/DDBJ accession number AF048695 ) was constructed using pRK5myc (30 (link)) and a cDNA clone derived from American Type Culture Collection (no. 569886; Rockville, MD) and the NIH Image consortium (est no. ma36d03; National Institutes of Health, Bethesda, MD). The cloned PI 5-kinase is a variant of mouse type I alpha PI 5-kinase. Plasmid regions that had been amplified using PCR were sequenced to check for errors. Antibodies to Arp3, p34, and p21 of the Arp2/3 complex (65 (link)), CP-β2 (53 (link)), actin (mAb C4) (32 (link)), VASP (10 (link)), zyxin (36 (link)), mena (20 (link)), ezrin (3 (link)), and profilin (38 (link)) were as described. Anti-vinculin was purchased from Sigma (St. Louis, MO). Antibody to PI 4,5-P2 was purchased from perSeptive Diagnostics (Framingham, MA) and was injected at 11 mg/ml, a concentration that had effects in other studies (21 (link)). Antibodies to myosin IIA and myosin IIB were gifts from R. Wysolmerski (St. Louis University, St. Louis, MO); anti–myosin V (17 (link)) and anti–myosin I (34 (link)) were as described. A peptide based on a polyphosphoinositide-binding site in gelsolin (residues 150– 169) (28 (link)) was synthesized and injected at 10 mM. Rhodamine-labeled secondary antibodies were purchased from Chemicon (Temecula, CA). Rhodamine dextrans were purchased from Sigma .
1-Phosphatidylinositol 3-Kinase
1-Phosphatidylinositol 4-Kinase
Actin-Related Protein 2-3 Complex
Actins
Antibodies
Bacteria
Binding Sites
CDC42 protein, human
Diagnosis
DNA, Complementary
ezrin
Gelsolin
Gifts
Immunoglobulins
Lim Kinases
Mus
Myosin Type I
Myosin Type V
Nonmuscle Myosin Type IIA
Nonmuscle Myosin Type IIB
Peptides
Phosphatidylinositol Phosphates
Plasmids
Profilins
RHOA protein, human
Rhodamine
rhodamine dextran
Transferase
VASP protein, human
Vinculin
ZYX protein, human
Most recents protocols related to «Vinculin»
The ROs were pooled (10) and lysed in radioimmunoprecipitation assay protein lysis buffer (Abcam) with protease inhibitor cocktail (Roche, Basel, Switzerland) and homogenized using a 25G needle. The protein concentration was assessed using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions and the plate absorbance was read in the SpectraMAX plate reader (Molecular Devices, San Jose, CA, USA) at 562 nm. The samples (22.5–85 μg) were loaded on 4–20% Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad), ran for the first 30 min at 70 V and the next 4 h at 100 V in Tris-Glycine SDS buffer. The gels were transferred to PVDF membranes (Merck KGaA) previously activated with methanol, in 1× Tris-Glycine buffer and 20% methanol at 70 mV overnight at 4°C. The membranes were rinsed in PBS-0.1% Tween, blocked in Pure Odyssey Blocking Buffer (Li-COR Biosciences, Lincoln, NE, USA) for 2 h and incubated with an anti-ABCA4 clone 5B4 (1:1,000; Merck KGaA) and anti-vinculin (1:5,000; Abcam) at 4°C overnight. The membranes were washed with PBS-0.1% Tween and incubated with Goat Anti-Mouse IRDye 800 and Goat Anti-Rabbit IRDye 680 (1:5000; Li-COR Biosciences) for 1.5 h in the dark. The membranes were washed with PBS-0.1% Tween and scanned wet in the Odyssey IR system (Li-COR Biosciences). The intensity of the detected bands was quantified using FIJI ImageJ 1.53c, and the samples were normalized to the wild-type sample. The mean percentage of the detected ABCA4 protein was statistically analyzed using GraphPad Prism 9, with ordinary one-way ANOVA test followed by Dunnet’s multiple comparison test.
Full text: Click here
Biological Assay
Buffers
Clone Cells
Gels
Glycine
Goat
IRDye800
Medical Devices
Methanol
Mice, House
Needles
neuro-oncological ventral antigen 2, human
polyvinylidene fluoride
prisma
Protease Inhibitors
Proteins
Rabbits
Radioimmunoprecipitation Assay
Tissue, Membrane
Tromethamine
Tweens
Vinculin
Cell lysate preparation, SDS-PAGE, and Western blotting were carried out according to standard protocol. Proteins were harvested in cell lysis buffer supplemented with proteinase inhibitor cocktail (P8340; Sigma-Aldrich) and phosphatase inhibitor cocktail 2 (P5726; Sigma-Aldrich). Antigen detection was performed using antibodies directed against c-Src (rabbit anti-mouse/human antibody; #2109; Cell Signaling), Ctsk (mouse anti-mouse/human antibody; sc-48353; Santa Cruz), Rho (mouse anti-mouse/human antibody; #05-778; Millipore), galectin-3 (mouse anti-mouse/human antibody; ab2785; Abcam; epitopes mapped within the N-terminal region), Lrp1 (mouse anti-mouse antibody; MABN1796; Millipore), Mmp9 (rabbit anti-mouse antibody; ab38898; Abcam), Mmp14 (rabbit anti-mouse antibody; ab53712; Abcam), OXPHOS (rabbit anti-mouse antibody; ab110413; Abcam), vinculin (mouse anti-mouse antibody; V9131; Sigma-Aldrich), β3 integrin (rabbit anti-mouse antibody; #4702; Cell Signaling), or β-actin (rabbit anti-mouse antibody; #4970; Cell Signaling). Goat anti-rabbit IgG horseradish peroxidase (#65-6120; Thermofisher Scientific) or goat anti-mouse IgG horseradish peroxidase (#32430; Thermofisher Scientific) were used as secondary antibody. Bound primary antibodies (diluted to 1:1,000) were detected with horseradish peroxidase–conjugated species-specific secondary antibodies (Santa Cruz; diluted to 1:2,000) using the Super Signal Pico system (Thermo Fisher Scientific).
For immunoprecipitation analysis, cells were solubilized in IP Lysis Buffer (#87788; Thermo Fisher Scientific) supplemented with complete protease inhibitor cocktail (Roche). Immunoprecipitation was performed by incubation with a mouse monoclonal IgG (#5415; Cell Signaling) or anti–galectin-3 antibody (sc-32790; Santa Cruz) followed by the addition of Protein A/G Magnetic Beads (#88803; Thermo Fisher Scientific). Immune complexes were separated by electrophoresis followed by blotting with antibodies directed against Lrp1 (MABN1796; Millipore) and galectin-3 (ab2785; Abcam).
For immunoprecipitation analysis, cells were solubilized in IP Lysis Buffer (#87788; Thermo Fisher Scientific) supplemented with complete protease inhibitor cocktail (Roche). Immunoprecipitation was performed by incubation with a mouse monoclonal IgG (#5415; Cell Signaling) or anti–galectin-3 antibody (sc-32790; Santa Cruz) followed by the addition of Protein A/G Magnetic Beads (#88803; Thermo Fisher Scientific). Immune complexes were separated by electrophoresis followed by blotting with antibodies directed against Lrp1 (MABN1796; Millipore) and galectin-3 (ab2785; Abcam).
Actins
anti-IgG
Antibodies
Antibodies, Anti-Idiotypic
Antigens
Buffers
Cells
Complex, Immune
CTSK protein, human
Electrophoresis
Epitopes
G-substrate
Galectin 3
Goat
GTP-Binding Proteins
Homo sapiens
Horseradish Peroxidase
Immunoglobulins
Immunoprecipitation
Integrin beta3
MMP9 protein, human
MMP14 protein, human
Mus
Protease Inhibitors
protein phosphatase inhibitor-2
Proteins
Rabbits
SDS-PAGE
Staphylococcal Protein A
Vinculin
Frozen liver tissues were homogenised in 400 µl of ice-cold RIPA buffer (10 mM Tris–HCl pH 7.4, 150 mM NaCl, 5 mM EDTA pH 8.0, 1 mM NaF, 0.1% SDS, 1% Triton X-100, 1% Sodium Deoxycholate with freshly added 1 mM NaVO4 and protease inhibitors) using a PowerGen 125 homogeniser and lysates normalised to 1 µg per 1 µl. Proteins were separated on a 4–12% Bis–Tris gel by SDS-PAGE and transferred onto nitrocellulose membrane.
Membranes were probed for the following; phospho-AKT (Ser 473, cat: 4060), total Akt (cat: 4691), phospho-S6 (Ser 235/236, cat: 4858), total S6 (cat: 2217), phospho-AMPK (Thr 172, cat: 2535), total AMPK (cat: 5832) and GAPDH (cat: 5174) (all Cell Signaling Technology), DEGS1 (cat: ab185237, Abcam), RBP4 (Dako), or IR β-chain (Santa Cruz Biotechnology). ApoB 48, ApoB 100 (Meridian Life Sciences UK, cat: K23300R) and Vinculin (Cell Signaling Technology, cat: 13901) were separated on a 6% Tris–Glycine gel. Anti-rabbit and anti-mouse horse radish peroxidase (HRP) conjugated antibodies were from Anaspec. Primary and secondary antibodies were used at 1:1000 and 1:5000 respectively.
Blots used in figures are all compliant with the digital image and integrity policies of Nature publishing and Scientific Reports journal. Western blot membranes were cut at approximate molecular weight (± 20 kDa) of target protein before incubation of primary antibodies. Equal numbers of representative samples from all treatment groups were run on multiple gels/blots to accommodate all samples. Images obtained were minimally processed. Image analysis and quantification with normalisation to loading control protein was performed within the same membrane and then data combined for graphical representation. No direct quantitative comparisons between samples on different gels/blots were performed.
Membranes were probed for the following; phospho-AKT (Ser 473, cat: 4060), total Akt (cat: 4691), phospho-S6 (Ser 235/236, cat: 4858), total S6 (cat: 2217), phospho-AMPK (Thr 172, cat: 2535), total AMPK (cat: 5832) and GAPDH (cat: 5174) (all Cell Signaling Technology), DEGS1 (cat: ab185237, Abcam), RBP4 (Dako), or IR β-chain (Santa Cruz Biotechnology). ApoB 48, ApoB 100 (Meridian Life Sciences UK, cat: K23300R) and Vinculin (Cell Signaling Technology, cat: 13901) were separated on a 6% Tris–Glycine gel. Anti-rabbit and anti-mouse horse radish peroxidase (HRP) conjugated antibodies were from Anaspec. Primary and secondary antibodies were used at 1:1000 and 1:5000 respectively.
Blots used in figures are all compliant with the digital image and integrity policies of Nature publishing and Scientific Reports journal. Western blot membranes were cut at approximate molecular weight (± 20 kDa) of target protein before incubation of primary antibodies. Equal numbers of representative samples from all treatment groups were run on multiple gels/blots to accommodate all samples. Images obtained were minimally processed. Image analysis and quantification with normalisation to loading control protein was performed within the same membrane and then data combined for graphical representation. No direct quantitative comparisons between samples on different gels/blots were performed.
Full text: Click here
Anti-Antibodies
Antibodies
Apolipoprotein B-48
Apolipoprotein B-100
Bistris
Buffers
Cold Temperature
Deoxycholic Acid, Monosodium Salt
Edetic Acid
Freezing
GAPDH protein, human
Gels
Glycine
Horseradish Peroxidase
Liver
Meridians
Mus
Nitrocellulose
PER1 protein, human
Protease Inhibitors
Proteins
Protein Targeting, Cellular
Rabbits
Radioimmunoprecipitation Assay
RBP4 protein, human
SDS-PAGE
Sodium Chloride
Tissue, Membrane
Tissues
Triton X-100
Tromethamine
Vinculin
Western Blotting
Full-length WT talin-1 plasmid containing internal GFP and RFP (Kumar et al., 2016 (link)) was used in this study. Nucleotides corresponding to the 17-residue region of the 17b splice variant were cloned into WT talin-1 by Gibson assembly. Briefly, the WT talin-1 plasmid was digested with NotI and XhoI. Primers containing overhangs of nucleotides corresponding to the 17-residue region of the splice variant were used to amplify R2. Two fragments containing nucleotides between the NotI site to R1 domain and beyond R2 domain to XhoI site were also amplified by PCR. All fragments were incubated with Gibson assembly mix (New England Biolabs) as per manufacturer’s instructions.
Talin-2 was knocked down in Tln1−/− cells (Priddle et al., 1998 (link)) by transient transfection of Tln2 siRNA (ONTARGET-plus Smartpool siRNA, Catalog ID:L-065877-00-0005, Horizon Discovery) and scrambled siRNA (AM4636; Ambion), using Lipofectamine RNAimax, as described previously (Kumar et al., 2016 (link)). Knockdown was confirmed by immunoblotting for talin-2 using mouse anti-talin-2 antibody (AC14-0126; Abcore). These cells were transfected with full-length WT talin-1 and full-length talin-1-17b variant, using Lipofectamine 2000 (Thermo Fisher Scientific) for 24 h and trypsinized for all experiments at this time point. For early adhesion analysis, Tln1−/−transfected cells were held in suspension for 30 min and plated on fibronectin-coated glass bottom dishes for 15 min, 30 min, 1 h, and 4 h. Cells were fixed in 4% paraformaldehyde and counterstained with Alexa 405 phalloidin (Thermo Fisher Scientific) and anti-vinculin antibody (V9131; Sigma-Aldrich). Cells were imaged using a 63× objective on a Leica SP8 confocal microscope. ImageJ was used to assess cell area, focal adhesion area, focal adhesion number and mean fluorescence intensities of vinculin and talin within each adhesion. To assess substrate stiffness–dependent cell spreading, cells were trypsinized and plated on either fibronectin-coated (10 µg/ml) glass-bottom dishes or polyacrylamide gels of varying stiffness. At 6 h, cells were fixed in 4% paraformaldehyde and counterstained with Alexa 647 phalloidin (Thermo Fisher Scientific). The cell area was calculated using ImageJ.
For tensin-1 localization, cells were plated for 48 h and counter-stained with tensin-1 (SAB4200283; Sigma-Aldrich). Talin adhesions that were within 7 µm from centroid of the cell were considered central adhesions and tensin intensity was quantified within these adhesions. Mean of tensin intensity within central adhesions was divided by mean of tensin intensity of peripheral adhesions in each cell and the ratio was plotted. β-catenin staining was also performed on densely seeded cells using anti-β-catenin antibody (9562; CST).
Talin-2 was knocked down in Tln1−/− cells (Priddle et al., 1998 (link)) by transient transfection of Tln2 siRNA (ONTARGET-plus Smartpool siRNA, Catalog ID:L-065877-00-0005, Horizon Discovery) and scrambled siRNA (AM4636; Ambion), using Lipofectamine RNAimax, as described previously (Kumar et al., 2016 (link)). Knockdown was confirmed by immunoblotting for talin-2 using mouse anti-talin-2 antibody (AC14-0126; Abcore). These cells were transfected with full-length WT talin-1 and full-length talin-1-17b variant, using Lipofectamine 2000 (Thermo Fisher Scientific) for 24 h and trypsinized for all experiments at this time point. For early adhesion analysis, Tln1−/−transfected cells were held in suspension for 30 min and plated on fibronectin-coated glass bottom dishes for 15 min, 30 min, 1 h, and 4 h. Cells were fixed in 4% paraformaldehyde and counterstained with Alexa 405 phalloidin (Thermo Fisher Scientific) and anti-vinculin antibody (V9131; Sigma-Aldrich). Cells were imaged using a 63× objective on a Leica SP8 confocal microscope. ImageJ was used to assess cell area, focal adhesion area, focal adhesion number and mean fluorescence intensities of vinculin and talin within each adhesion. To assess substrate stiffness–dependent cell spreading, cells were trypsinized and plated on either fibronectin-coated (10 µg/ml) glass-bottom dishes or polyacrylamide gels of varying stiffness. At 6 h, cells were fixed in 4% paraformaldehyde and counterstained with Alexa 647 phalloidin (Thermo Fisher Scientific). The cell area was calculated using ImageJ.
For tensin-1 localization, cells were plated for 48 h and counter-stained with tensin-1 (SAB4200283; Sigma-Aldrich). Talin adhesions that were within 7 µm from centroid of the cell were considered central adhesions and tensin intensity was quantified within these adhesions. Mean of tensin intensity within central adhesions was divided by mean of tensin intensity of peripheral adhesions in each cell and the ratio was plotted. β-catenin staining was also performed on densely seeded cells using anti-β-catenin antibody (9562; CST).
Full text: Click here
Antibodies, Anti-Idiotypic
ARID1A protein, human
Cells
CTNNB1 protein, human
Fluorescence
FN1 protein, human
Focal Adhesions
Hyperostosis, Diffuse Idiopathic Skeletal
Lipofectamine
lipofectamine 2000
Microscopy, Confocal
Mus
Nucleotides
Oligonucleotide Primers
paraform
Phalloidine
Plasmids
polyacrylamide gels
RNA, Small Interfering
Talin
Tensin
Tissue Adhesions
Transfection
Transients
Vinculin
Cells were lysed using radio-immunoprecipitation assay (RIPA) buffer (Thermo Fisher Scientific, Waltham, MA, Cat #89900) supplemented with protease and phosphatase inhibitors (Thermo Fisher Scientific, #78440) and 0.5 M Ethylenediaminetetraacetic acid (EDTA) (#78440, Thermo Fisher Scientific). Lysates were centrifuged at 14,000 rpm for 15 min at 4 °C. Protein concentrations were determined using PierceTM BCA Protein Assay Kit reagent (Thermo Fisher Scientific, #23227) and separated by electrophoresis on NuPAGETM 4 to 12% Bis-Tris, 1.0, Protein gel (Invitrogen, Waltham, MA). Antibodies were added according to the manufacturers recommended conditions. Antibodies used include anti-p53R2 + RRM2 antibody (abcam, Cambridge, United Kingdom, ab209995, 1:10000), anti-RRM2 antibody (abcam, ab172476, 1:5000), phospho-NF-κB p65 (Ser536)(93H1) Rabbit mAb (CST #3033, 1:1000), NF-κB p65(D14E12)XP Rabbit antibody (CST #8242, 1:1000), Phospho-AMPKα (Thr172) antibody (CST #2531, 1:1000), p53 (7F5) Rabbit mAb(CST #2527, 1:1000). Equal protein loading was confirmed using anti-vinculin antibody (abcam, ab219649, 1:5000). Molecular weight marker EZ-RunTM prestained protein ladder (Thermo Fisher Scientific, BP3603500) was used to confirm the expected size of the proteins of interest. Immunoblots were developed with SuperSignalTM West Femto Maximum Sensitivity Substrate (# 34095, Thermo Fisher Scientific) and imaged on a LiCor ODYSSEY Fc (LiCor Inc. Lincoln, NE, Model # 2800). Protein bands were quantified using Image Studio™ Acquisition Software (LI-COR) and normalized to the control bands.
Full text: Click here
Antibodies
Antibodies, Anti-Idiotypic
Biological Assay
Bistris
Buffers
Cells
Edetic Acid
Electrophoresis
Hypersensitivity
Immunoblotting
Immunoglobulins
Immunoprecipitation
inhibitors
Peptide Hydrolases
Phosphoric Monoester Hydrolases
Proteins
Rabbits
RRM2 protein, human
Transcription Factor RelA
Vinculin
Top products related to «Vinculin»
Sourced in United States, Germany, United Kingdom, Denmark
Vinculin is a cytoskeletal protein that plays a key role in cell-cell and cell-matrix adhesion. It functions as a linker between the actin cytoskeleton and the cell membrane, providing structural integrity and facilitating cell-cell and cell-matrix interactions.
Sourced in United States, United Kingdom, Germany, Italy, Belgium, France
Anti-vinculin is a laboratory reagent used in cell biology research. It is a monoclonal antibody that specifically binds to the protein vinculin, which is involved in cell-cell and cell-matrix adhesion. Anti-vinculin is commonly used in techniques such as Western blotting, immunoprecipitation, and immunocytochemistry to detect and study the expression and localization of vinculin in various cell types and samples.
Sourced in United States, United Kingdom
Vinculin is a cytoplasmic protein that plays a key role in the regulation of cell-cell and cell-matrix adhesions. It acts as a linker between the actin cytoskeleton and the cell membrane, facilitating the transmission of mechanical forces and signal transduction.
Sourced in United States, United Kingdom, Germany
Vinculin is a cytoskeletal protein that plays a crucial role in cell-cell and cell-matrix adhesion. It is involved in the regulation of actin filament organization and the formation of focal adhesions.
Sourced in United States, Germany, China, United Kingdom, Morocco, Ireland, France, Italy, Japan, Canada, Spain, Switzerland, New Zealand, India, Hong Kong, Sao Tome and Principe, Sweden, Netherlands, Australia, Belgium, Austria
PVDF membranes are a type of laboratory equipment used for a variety of applications. They are made from polyvinylidene fluoride (PVDF), a durable and chemically resistant material. PVDF membranes are known for their high mechanical strength, thermal stability, and resistance to a wide range of chemicals. They are commonly used in various filtration, separation, and analysis processes in scientific and research settings.
Sourced in United States, United Kingdom, Germany, China, Canada, Japan, Macao, Italy, Sao Tome and Principe, Israel, Spain, Denmark, France, Finland, Australia, Morocco, Ireland, Czechia, Sweden, Uruguay, Switzerland, Netherlands, Senegal
β-actin is a protein that is found in all eukaryotic cells and is involved in the structure and function of the cytoskeleton. It is a key component of the actin filaments that make up the cytoskeleton and plays a critical role in cell motility, cell division, and other cellular processes.
Sourced in United States, United Kingdom
Vinculin is a cytoskeletal protein that functions as a linkage between the actin cytoskeleton and cell-cell or cell-matrix adhesion sites. It plays a role in the regulation of cell-cell and cell-matrix junctions, as well as in the organization of the actin cytoskeleton.
Sourced in United States
Anti-vinculin is a primary antibody that recognizes the vinculin protein. Vinculin is a cytoskeletal protein involved in cell-cell and cell-matrix junctions, playing a role in cell adhesion and signaling.
Sourced in United States, United Kingdom, Germany
The V9131 is a laboratory equipment product manufactured by Merck Group. It is designed for use in research and scientific applications. The core function of the V9131 is to [insert brief, factual description of the product's core function without interpretation or extrapolation].
Sourced in United States, Germany, Italy, United Kingdom, Canada, France, China, Switzerland, Japan, Spain, Australia, Sweden, Portugal, Israel, Netherlands, Belgium
Nitrocellulose membranes are a type of laboratory equipment designed for use in protein detection and analysis techniques. These membranes serve as a support matrix for the immobilization of proteins, enabling various downstream applications such as Western blotting, dot blotting, and immunodetection.
More about "Vinculin"
Vinculin, a pivotal cytoskeletal protein, plays a crucial role in cell-cell and cell-matrix adhesion processes.
It is a key component of focal adhesions, which are essential for cell migration, signaling, and force transmission.
Vinculin interacts with a variety of other proteins, such as actin, talin, and α-actinin, to mediate these critical adhesive functions.
Dysregulation of vinculin has been implicated in a range of diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions.
Understanding the intricate roles and regulation of vinculin is an active area of research, with promising therapeutic applications.
Researchers often utilize tools like anti-vinculin antibodies, PVDF and nitrocellulose membranes, and the vinculin-related protein β-actin to study vinculin and its associated pathways.
The V9131 antibody is a commonly used tool for vinculin detection and analysis.
By exploring the latest vinculin research across literature, preprints, and patents, scientists can uncover valuable insights and optimize their protocols using AI-driven platforms like PubCompare.ai.
This data-driven approach helps identify the most effective methods and products for vinculin-related studies, advancing our understanding of this critical cytoskeletal component and its implications for human health and disease.
It is a key component of focal adhesions, which are essential for cell migration, signaling, and force transmission.
Vinculin interacts with a variety of other proteins, such as actin, talin, and α-actinin, to mediate these critical adhesive functions.
Dysregulation of vinculin has been implicated in a range of diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions.
Understanding the intricate roles and regulation of vinculin is an active area of research, with promising therapeutic applications.
Researchers often utilize tools like anti-vinculin antibodies, PVDF and nitrocellulose membranes, and the vinculin-related protein β-actin to study vinculin and its associated pathways.
The V9131 antibody is a commonly used tool for vinculin detection and analysis.
By exploring the latest vinculin research across literature, preprints, and patents, scientists can uncover valuable insights and optimize their protocols using AI-driven platforms like PubCompare.ai.
This data-driven approach helps identify the most effective methods and products for vinculin-related studies, advancing our understanding of this critical cytoskeletal component and its implications for human health and disease.